OUR PORTFOLIO
The current portfolio comprises 13 companies: NeuroAdjuvants, Sera Prognostics, ContraDyn, MedCatheters, Q Therapeutics, Elute, XableCath, MedAnalytics, JST Research, Veritract, Complexa, PhotoPharmics and Catheter Connections.
Current Investments
Sera Prognostics, Inc.
www.seraprognostics.comMedCatheters, Inc.
Q Therapeutics
www.qthera.comJST Research
Elute, Inc.
www.elutinc.comVeritract
www.veritract.comComplexa, Inc.
www.complexarx.com/PhotoPharmics, Inc.
www.photopharmics.comXablecath
www.xablecath.comNeuroadjuvants
ContraDyn, Inc
MedAnalytics, Inc
Catheter Connections, Inc.
Show More
Past Investments
Decipher GenX, Inc.
Numira, Inc.
G6, Inc.
Show More